The 54th Costenbader Society Annual Meeting

Ottawa, ON CA

August 9, 2024 to August 10, 2024

Overview

The Costenbader Society, which is the Alumni Society of the Pediatric Ophthalmology Fellowship Program at Children’s National Hospital and The George Washington University, will convene on the mornings of August 9 and 10, 2024, in Ottawa, Canada. The agenda includes the presentation of scientific papers and case reports, fostering ample discussion among peers in Pediatric Ophthalmology. Many of these peers are national and international leaders in the field. The meeting will also provide a platform for discussing new research and innovations, as well as clinical and surgical management modalities. There will be an exchange of insights and experiences, enriching the knowledge of all participants.

Target Audience

This activity is intended to meet the educational needs of the healthcare team including but not limited to:

Pediatric Ophthalmologists
Graduates of the Pediatric Ophthalmology Fellowship Program at Children's National Hospital/The George Washington University)

Learning Objectives

After participating in this activity, learners will be able to:

Learn the new diagnostic (clinical and genetic) criteria and surgical management skills of pediatric cataract. Comprehend the new approaches to manage Strabismus in adults and children.
Understand the practice management and medicolegal issues facing the practice of Pediatric Ophthalmology and come up with strategies to resolve them.

Course summary

Available credit:

9.00 AMA PRA Category 1 Credit™
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
9.00 Completion

Course opens:

08/01/2024

Course expires:

10/10/2024

Event starts:

08/09/2024 - 8:00am EDT

Event ends:

08/10/2024 - 1:00pm EDT

Add to calendar:

Venue

Lord Elgin Hotel, Ottawa, ON, Canada

100 Elgin Street

Ottawa, ON K1P 5K8

Canada

Faculty

Faculty & Disclosure

Planning Committee

Mohamad S. Jaafar, MD (Activity Director)

Faculty

Lauren Yeager

Jonathan Taylormoore

Jonathan Salvin, MD

Gennifer Greebel

Marlet Bazemore

Francisco Javier Solano Moncado

Elias Traboulsi

Sherwin Isenberg

Mary Louise Collins

Becca Mets-Halgrimson

Marylin Mets

Irene Ludwig

John Baker, MD

James Richard, MD

Marion Edward Wilson

Lea Ann Lope

Jack Baker

Majida Gaffar

Laryssa Huryn

Srimath Jain

Martin Lederman

Mark Greenwald

Disclosure of Relevant Financial Relationships

In accordance with The Standards for Integrity and Independence, GW requires all planners, faculty, and others in control of educational content to disclose the absence or existence of all financial relationships (of any dollar amount) with any ineligible companies within the past 24 months. We define ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

GW reviews all disclosure statements to determine which financial relationships are relevant to the educational content of the CE Activity.  An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

Disclosure Statement(s)

Relevant Financial Relationships

Upon review of all collected information about financial relationships with ineligible companies, GW has determined that the following individuals in a position to control the content of this educational activity have relevant financial relationships with ineligible companies.

An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.

All relevant financial relationships listed for these individual(s) have been mitigated.

Marion Edward Wilson, a speaker for this accredited CE activity, is a consultant for and received research funding from Vertex Pharma; Ophtec; Ocular Therapeutix; EyePoint Pharma.

Absence of Relevant Financial Relationships

All others in a position to control the content of this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Disclaimer

The information in this educational activity is provided for general medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options of a specific patient’s medical condition. The viewpoints expressed in this CME activity are those of the authors/faculty. They do not represent an endorsement by The George Washington University.

Accreditation

Accreditation Statements

The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement(s)

Physicians (CME)

The George Washington University School of Medicine and Health Sciences designates this live activity for a maximum of 9.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Healthcare Professionals (Attendance)

All other healthcare professionals who successfully complete the activity will receive a Certificate of Attendance. Many credentialing bodies such as the ANCC, AANP, and AAPA accept certificates of attendance for educational activities certified for AMA PRA Category 1 Credit(s)™ from organizations accredited by the ACCME. If you have doubts about whether an activity will qualify for CE, please contact your certifying organization for clarification on credit eligibility.

Available Credit

9.00 AMA PRA Category 1 Credit™
The George Washington University School of Medicine and Health Sciences is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
9.00 Completion